Clinical Trials Directory

Trials / Completed

CompletedNCT01602796

Effectiveness of Intervention on Reducing the Prevalence of Smoking Among Adolescents

Effectiveness of a Complex Intervention on Reducing the Prevalence of Smoking Among Adolescents: a Cluster Randomized Control Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2,226 (actual)
Sponsor
Fundació d'investigació Sanitària de les Illes Balears · Other Government
Sex
All
Age
11 Years – 14 Years
Healthy volunteers
Not accepted

Summary

In this multicenter cluster randomized controlled trial stratified by school baseline prevalence of smoking will be randomly allocated to the control or intervention group. Control schools will receive normal smoking education and intrvention schools will receive a four year class-based curriculum intervention (22 Classroom lessons), reinforcement of smoke-free school policy, smoking cessation in parents, pupils, and teachers and information and annual meeting with parents. Study participants will be children aged 12 to 15 years old ; they will be followed to 2 years after high school. External evaluator and analyst will be blinded to school allocation. The aim of this study is to analyze the effectiveness of a complex intervention to reduce the prevalence of smoking at 3º ESO (14-15 yrs-old) and 2 years after high school (17-18 yrs-old) .

Conditions

Interventions

TypeNameDescription
BEHAVIORALSchool interventionThe ITACA intervention is a cognitive and social-influences approach to prevent tobacco consumption. The intervention is integrated in the curricula of the school, also schools are reinforced to follow a smoke-free school and strictly follow legislation about smoking in schools. The community component include annual meeting with adolescents parents and parents and teachers intensive group for smoking cessation.

Timeline

Start date
2011-09-01
Primary completion
2019-09-01
Completion
2020-09-01
First posted
2012-05-21
Last updated
2021-03-10

Locations

20 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT01602796. Inclusion in this directory is not an endorsement.